Latest REGN reports update at 2024-02-05: 2023 ∙ 2022 ∙ 2021
  1. Home
  2. Stock quotes
  3. Stock Regeneron Pharmaceuticals
Regeneron Pharmaceuticals logo

Regeneron Pharmaceuticals REGN

$ 883.2 -0.84%
mail-toReport an Error

Country

 usaUSA

IPO year

 1991

Industry

 Biotechnology

Stock Exchange

 NASDAQ GLOBALSPB

CEO

 Dr. Leonard Schleifer

Employees in the company

 8 314

Shares

 107 M

Market Cap[1]

 $ 94.2 B

EBITDA (LTM)

 $ 4.95 B

P/E (LTM)

 21.28

P/S (LTM)

 6.95

EPS (LTM)

 38.48

Regeneron Pharmaceuticals is an American biotechnology company that specializes in the development and production of innovative medical treatments. The company was founded in 1988 in New York.

Regeneron Pharmaceuticals' main areas of focus are research and development of drugs for the treatment of various diseases, including oncological, autoimmune, infectious, and others.

One of the company's most well-known products is Eylea, which is used to treat age-related macular degeneration. In addition, Regeneron Pharmaceuticals is developing drugs for the treatment of cancer, Alzheimer's disease, Parkinson's disease, and other conditions.

The company invests heavily in scientific research and development to create innovative and effective drugs. Regeneron Pharmaceuticals collaborates with universities, research centers, and other companies to expand its scientific potential and improve its products.

Regeneron Pharmaceuticals has a wide network of distributors and partners around the world, enabling it to provide its products to patients in various countries. The company strives for continuous improvement of its products and expansion of its activities to meet the needs of patients worldwide.

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Pluristem Therapeutics Pluristem Therapeutics
PSTI
 		$ 1.03 -1.9 % $ 33.3 M Nasdaq Global Select Market israelIsrael
Cortexyme Cortexyme
CRTX
 		$ 1.88 -1.05 % $ 67.1 M Nasdaq Global Select Market,SPB usaUSA
Sorrento Therapeutics Sorrento Therapeutics
SRNE
 		$ 0.27 -29.58 % $ 126 M Nasdaq Global Select Market usaUSA
Cerus Corporation Cerus Corporation
CERS
 		$ 1.71 0.59 % $ 308 M Nasdaq Global Market usaUSA
Caladrius Biosciences Caladrius Biosciences
CLBS
 		$ 0.43 -16.75 % $ 25.8 M Nasdaq Capital Market usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
 		$ 1.47 -5.16 % $ 5.39 M Nasdaq Capital Market usaUSA
Orchard Therapeutics plc Orchard Therapeutics plc
ORTX
 		$ 4.93 1.02 % $ 90.8 M Nasdaq Global Select Market britainBritain
Cue Biopharma Cue Biopharma
CUE
 		$ 1.37 -3.19 % $ 62.7 M Nasdaq Capital Market,SPB usaUSA
Advaxis Advaxis
ADXS
 		$ 0.31 -9.65 % $ 45.9 M Nasdaq Capital Market usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
 		$ 11.21 0.36 % $ 1.44 B Nasdaq Capital Market usaUSA
Heat Biologics, Inc. Heat Biologics, Inc.
HTBX
 		$ 3.93 -5.76 % $ 99.8 M Nasdaq Capital Market usaUSA
La Jolla Pharmaceutical Company La Jolla Pharmaceutical Company
LJPC
 		$ 6.2 - $ 154 M Nasdaq Capital Market usaUSA
Zymeworks Zymeworks
ZYME
 		$ 6.42 - $ 404 M NYSE canadaCanada
Fennec Pharmaceuticals Fennec Pharmaceuticals
FENC
 		$ 9.21 0.55 % $ 245 M Nasdaq Capital Market usaUSA
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
 		$ 10.5 - $ 231 M Nasdaq Global Market usaUSA
CEL-SCI Corporation CEL-SCI Corporation
CVM
 		$ 1.44 -1.71 % $ 68.3 M NYSE American,SPB usaUSA
Kadmon Holdings, Inc. Kadmon Holdings, Inc.
KDMN
 		$ 9.5 - $ 1.7 B Nasdaq Global Select Market usaUSA
AIkido Pharma AIkido Pharma
AIKI
 		$ 3.17 1.93 % $ 17.4 M Nasdaq Capital Market usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
 		$ 2.58 -4.8 % $ 255 M Nasdaq Global Select Market usaUSA
Zosano Pharma Corporation Zosano Pharma Corporation
ZSAN
 		$ 0.56 7.23 % $ 2.72 M Nasdaq Global Select Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.